BRETAZENIL
UNII OSZ0E9DGOJ

Substance Identification & Data

This profile provides standardized clinical and technical data for Bretazenil, uniquely identified by the FDA Unique Ingredient Identifier (UNII) OSZ0E9DGOJ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 84379-13-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

OSZ0E9DGOJ

CAS Registry Number

84379-13-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BRETAZENIL

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H20BrN3O3

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

LWUDDYHYYNNIQI-ZDUSSCGKSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C72111

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

107926

Unique identification number in the NCBI database of chemical substances.

INN ID

6319

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

DD-21

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1cc2-n3cnc(c3[C@@]4(CCCN4C(c2c(c1)Br)=O)[H])C(OC(C)(C)C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bretazenil. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.